Hydroxypropyl-β-cyclodextrin-based fast dissolving carbamazepine printlets prepared by semisolid extrusion 3D printing.


Journal

Carbohydrate polymers
ISSN: 1879-1344
Titre abrégé: Carbohydr Polym
Pays: England
ID NLM: 8307156

Informations de publication

Date de publication:
01 Oct 2019
Historique:
received: 15 03 2019
revised: 15 05 2019
accepted: 15 05 2019
entrez: 23 6 2019
pubmed: 23 6 2019
medline: 4 12 2019
Statut: ppublish

Résumé

This work aimed to explore for the first time the use of cyclodextrins to prepare printlets of poorly soluble drugs, such as carbamazepine, which require fine dose adjustment and rapid release. Orodispersible (flash) and immediate release formulations were 3D printed via semisolid extrusion of wet masses of hydroxypropyl-β-cyclodextrin (HPβCD) and cellulose ethers and regulating tablet porosity. Rheology of the wet masses allowed identifying printable compositions. Printing robustness was assessed evaluating weight, dimensions, hardness, drug content, and microstructure. Drug crystallinity, printlet disintegration and dissolution profiles were also characterized. The results highlight the feasibility of using HPβCD as excipient in printlets of poorly soluble drugs, and the possibilities of tuning drug release profiles through small changes in cellulose ethers nature and ratio. Semisolid extrusion-based 3D printing is revealed as a feasible approach to in situ form carbamazepine-HPβCD complexes and to produce printlets with suitable physical and drug release properties for oral delivery.

Identifiants

pubmed: 31227167
pii: S0144-8617(19)30557-0
doi: 10.1016/j.carbpol.2019.05.084
pii:
doi:

Substances chimiques

Anticonvulsants 0
Excipients 0
2-Hydroxypropyl-beta-cyclodextrin 1I96OHX6EK
Carbamazepine 33CM23913M
Carboxymethylcellulose Sodium K679OBS311

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

55-62

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Jaime Conceição (J)

UCIBIO - REQUIMTE, Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.

Xián Farto-Vaamonde (X)

Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, R+D Pharma Group (GI-1645), Facultad de Farmacia and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.

Alvaro Goyanes (A)

Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, R+D Pharma Group (GI-1645), Facultad de Farmacia and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain; FabRx Ltd., 3 Romney Road, Ashford, Kent TN24 0RW, United Kingdom.

Oluwatomide Adeoye (O)

Research Institute for Medicines (iMed.ULisboa), Department of Galenic Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.

Angel Concheiro (A)

Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, R+D Pharma Group (GI-1645), Facultad de Farmacia and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.

Helena Cabral-Marques (H)

Research Institute for Medicines (iMed.ULisboa), Department of Galenic Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.

José Manuel Sousa Lobo (JM)

UCIBIO - REQUIMTE, Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.

Carmen Alvarez-Lorenzo (C)

Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, R+D Pharma Group (GI-1645), Facultad de Farmacia and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain. Electronic address: carmen.alvarez.lorenzo@usc.es.

Articles similaires

Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Characterization of 3D printed composite for final dental restorations.

Lucas Eigi Borges Tanaka, Camila da Silva Rodrigues, Manassés Tércio Vieira Grangeiro et al.
1.00
Composite Resins Materials Testing Printing, Three-Dimensional Surface Properties Flexural Strength

Personalized bioceramic grafts for craniomaxillofacial bone regeneration.

Ana Beatriz G de Carvalho, Maedeh Rahimnejad, Rodrigo L M S Oliveira et al.
1.00
Humans Bone Regeneration Ceramics Printing, Three-Dimensional Tissue Scaffolds
Animals Rumen Methane Fermentation Cannabis

Classifications MeSH